Spear, B. B., Heath-Chiozzi, M. & Huff, J. Clinical application of pharmacogenetics. Trends Mol. Med. 7, 201–204 (2001).

Article  CAS  PubMed  Google Scholar 

Dowden, H. & Munro, J. Trends in clinical success rates and therapeutic focus. Nat. Rev. Drug Disc. 18, 495–496 (2019).

Article  CAS  Google Scholar 

Downing, N. S. et al. Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration Between 2001 and 2010. JAMA 317, 1854–1863 (2017).

Article  PubMed Central  PubMed  Google Scholar 

Lauschke, V. M. & Ingelman-Sundberg, M. Prediction of drug response and adverse drug reactions: from twin studies to Next Generation Sequencing. Eur. J. Pharm. Sci. 130, 65–77 (2019).

Article  CAS  PubMed  Google Scholar 

Lauschke, V. M., Zhou, Y. & Ingelman-Sundberg, M. Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity. Pharmacol. Ther. 197, 122–152 (2019).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Russell, L. E. et al. Pharmacogenomics in the Era of Next Generation Sequencing—from Byte to Bedside. Drug Metab Rev. 53, 253–278 (2021).

Article  PubMed  Google Scholar 

Pirmohamed, M. Pharmacogenomics: current status and future perspectives. Nat. Rev. Genet. 24, 350–362 (2023).

Article  CAS  PubMed  Google Scholar 

Schärfe, C. P., Tremmel, R., Schwab, M., Kohlbacher, O. & Marks, D. S. Genetic variation in human drug-related genes. Genome Med. 9, 117 (2017).

Article  PubMed Central  PubMed  Google Scholar 

Hauser, A. S. et al. Pharmacogenomics of GPCR drug targets. Cell 172, 41–54 (2018).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Zhou, Y. et al. Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine. Sci. Adv. 7, eabi6856 (2021).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Alkan, C., Coe, B. P. & Eichler, E. E. Genome structural variation discovery and genotyping. Nat. Rev. Genet. 12, 363–376 (2011).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Lappalainen, T., Scott, A. J., Brandt, M. & Hall, I. M. Genomic analysis in the age of human genome sequencing. Cell 177, 70–84 (2019).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Huddleston, J. et al. Discovery and genotyping of structural variation from long-read haploid genome sequence data. Genome Res. 27, 677–685 (2017).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Weischenfeldt, J., Symmons, O., Spitz, F. & Korbel, J. O. Phenotypic impact of genomic structural variation: insights from and for human disease. Nat. Rev. Genet. 14, 125–138 (2013).

Article  CAS  PubMed  Google Scholar 

Spielmann, M. & Mundlos, S. Looking beyond the genes: the role of non-coding variants in human disease. Hum. Mol. Genet. 25, R157–R165 (2016).

Article  CAS  PubMed  Google Scholar 

Spielmann, M., Lupiáñez, D. G. & Mundlos, S. Structural variation in the 3D genome. Nat. Rev. Genet. 19, 453–467 (2018).

Article  CAS  PubMed  Google Scholar 

Santos, M. et al. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet. Med. 20, 622–629 (2018).

Article  CAS  PubMed  Google Scholar 

Tremmel, R. et al. Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression. Hum. Genet. 139, 137–149 (2020).

Article  CAS  PubMed  Google Scholar 

Collins, R. L. et al. A structural variation reference for medical and population genetics. Nature 581, 444–451 (2020).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Hasin-Brumshtein, Y., Lancet, D. & Olender, T. Human olfaction: from genomic variation to phenotypic diversity. Trends Genet. 25, 178–184 (2009).

Article  CAS  PubMed  Google Scholar 

Jarvis, J. P., Peter, A. P. & Shaman, J. A. Consequences of CYP2D6 copy-number variation for pharmacogenomics in psychiatry. Front Psychiatry 10, 432 (2019).

Article  PubMed Central  PubMed  Google Scholar 

Hebbring, S. J. et al. Human SULT1A1 gene: copy number differences and functional implications. Hum. Mol. Genet. 16, 463–470 (2007).

Article  CAS  PubMed  Google Scholar 

Tremmel, R., Klein, K., Winter, S., Schaeffeler, E. & Zanger, U. M. Gene copy number variation analysis reveals dosage-insensitive expression of CYP2E1. Pharmacogenomics J. 16, 551–558 (2016).

Article  CAS  PubMed  Google Scholar 

Tirona, R. G. et al. The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat. Med. 9, 220–224 (2003).

Article  CAS  PubMed  Google Scholar 

Pérez, E., Bourguet, W., Gronemeyer, H. & de Lera, A. R. Modulation of RXR function through ligand design. Biochim. Biophys. Acta 1821, 57–69 (2012).

Article  PubMed  Google Scholar 

GTEx Consortium. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017).

Article  PubMed Central  Google Scholar 

Dalton, R. et al. Interrogation of CYP2D6 structural variant alleles improves the correlation between CYP2D6 genotype and CYP2D6‐mediated metabolic activity. Clin. Transl. Sci. 13, 147–156 (2020).

Article  CAS  PubMed  Google Scholar 

Nofziger, C. et al. PharmVar GeneFocus: CYP2D6. Clin. Pharmacol. Ther. 107, 154–170 (2020).

Article  CAS  PubMed  Google Scholar 

Hong, C. H. et al. Sphingosine 1-phosphate receptor 4 promotes nonalcoholic steatohepatitis by activating NLRP3 inflammasome. Cell Mol. Gastroenterol. Hepatol. 13, 925–947 (2022).

Article  PubMed  Google Scholar 

Cauffiez, C. et al. Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter region. Biochem. Pharmacol. 67, 2231–2238 (2004).

Article  CAS  PubMed  Google Scholar 

Ingelman-Sundberg, M., Mkrtchian, S., Zhou, Y. & Lauschke, V. M. Integrating rare genetic variants into pharmacogenetic drug response predictions. Hum. Genomics 12, 26 (2018).

Article  PubMed Central  PubMed  Google Scholar 

Hurles, M. E., Dermitzakis, E. T. & Tyler-Smith, C. The functional impact of structural variation in humans. Trends Genet. 24, 238–245 (2008).

Article  CAS  PubMed Central  PubMed  Google Scholar 

He, Y., Hoskins, J. M. & McLeod, H. L. Copy number variants in pharmacogenetic genes. Trends Mol. Med. 17, 244–251 (2011).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Usher, C. L. et al. Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. Nat. Genet. 47, 921–925 (2015).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Gamazon, E. R., Huang, R. S., Dolan, M. E. & Cox, N. J. Copy number polymorphisms and anticancer pharmacogenomics. Genome Biol. 12, R46–12 (2011).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Sudmant, P. H. et al. Global diversity, population stratification, and selection of human copy-number variation. Science 349, aab3761 (2015).

Article  PubMed Central  PubMed  Google Scholar 

Stranger, B. E. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848–853 (2007).

Article  CAS  PubMed Central  PubMed  Google Scholar 

Vijzelaar, R. et al. Multi-ethnic SULT1A1 copy number pr